Laurence J. Belin - Publications

Erratum to: A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: March 31, 2016

Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.

Journal: Surgery

Published: January 02, 2015

A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: May 30, 2014

Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.

Journal: Surgery

Published: February 20, 2014

Techniques for safe organ recovery after endovascular aortic and bariatric operations.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 14, 2014

Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.

Journal: Surgery

Published: January 03, 2014

An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma.

Journal: Surgery

Published: January 05, 2013

Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.

Journal: Breast cancer research : BCR

Published: May 17, 2012